Filing Details

Accession Number:
0001209191-22-016873
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-07 20:03:47
Reporting Period:
2022-03-03
Accepted Time:
2022-03-07 20:03:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288231 Phd P John Longenecker C/O Pacira Biosciences, Inc.
5401 West Kennedy Boulevard, Suite 890
Tampa FL 33609
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-03 7,000 $10.81 25,823 No 4 M Direct
Common Stock Disposition 2022-03-03 7,000 $71.74 18,823 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-03-03 7,000 $0.00 7,000 $10.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-06-04 No 4 M Direct
Footnotes
  1. The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012.